Oncology is not a push-over among the numerous branches of medicine. It centers on the diagnosis, prevention and treatment of cancer and some other related diseases. The plague of cancer is ravaging the world on a most worrisome proportion than ever before. The young are not exempted even though majority of cancer cases reside with the aged. Since we all pray to live long to enjoy the fruits of our labor, more effort must be jeered towards combating and putting a stop to the spread of this menace. This is where we need oncologists to take the center stage and give us the victory we earnestly desire. Mikhail Blagosklonny has proven beyond all doubts that he has what it takes to do just that.
Mikhail had always wanted to be an Oncologist of repute even while he was still in college. He made this explicitly clear to all and sundry when he took to medical school at the prestigious First Pavlov State Medical University of St. Petersburg where graduated with a MD in Internal Medicine and PhD in Experimental Medicine and Cardiology.
Know more: http://gettingstronger.org/tag/mikhail-blagosklonny/
He knew he needed a comprehensive working experience, so he had to strategize. He turned down some job opportunities that were capable of distancing him from his goal of being an erudite professor of Oncology. It is thus not an accident that he eventually worked and still works in some of the best medical institutions that address issues relating to cancer. The likes of New York Medical College, Ordway Research Institute and the Roswell Park Cancer Institute are some of the best medical instituting focusing on cancer. Mikhail Blagosklonny spent quality time working in all three and he is still with the Roswell Park Cancer Institute as an erudite professor of Oncology.
Make no mistake about it, his professorship is well deserved. He has distinguished himself as a force to be reckoned with in the field of Oncology. The world had no choice but to sing his praise when he formulated a theory on TOR signaling, which dealt fatal blows on the monster called cancer and aging. He gave unflinching support to the use of rapamycin as a veritable cancer drug, which could also be used to slow down the aging process making people enjoy longer life spans.
Also Mikhail Blagosklonny has endeared himself to millions of people in and out of the United States as his articles, books and reviews keep moving from one continent to the other. Many who could not meet him in person, have come to know much about cancer, its prevention and treatment options through his writings.
Mikhail Blagosklonny has so far proven that the status of a professor of Oncology must not stop at the name,but be justified with exploits that transcend national boundaries. Visit ResearchGate to keep up to date with Mikhail’s latest work.
Oncotarget is considered one of the most insightful peer review journals in the medical community today. As the work of Dr. Blagosklonny continues, the popularity of the journal continues to grow at breakneck speed. Those who work with Dr. Blagosklonny and read his work know that they are reading the best of his research and time spent working on ways to improve cancer treatment and prevent it as well. His work has been noted as constructive, punctual, and above all insightful by his peers as they read, research and attempt to raise the bar on their own clinical investigations.
This journal is also privileged to call on the help of Nobel Prize winner, Andrew Schally, and Carlo Croce, the Former Editor-in-Chief of Cancer Research. Having published multiple works in the Oncotarget journal, means that it is packed with tons of information that is ready to be read and researched by other oncologists around the world. Dr. Blagosklonny continues to involve some of the foremost researchers on cancer research, and is continually accepting papers regarding topics that are often published in the journal. There are other conditions related to aging that are submitted to the journal, and are often researched alongside cancer for clues and further study on how this may impact their condition and overall health. Read more about Oncotarget at Bioxbio.
Those who are seeking to be a part of a prestigious peer review journal need look no further. Oncotarget follows COPE, the Code of Conduct and Best Practice Guidelines to ensure that they can uphold the scholarly reputation that Dr. Blagosklonny has built with his career and this journal as a whole. The process used to determine whether or not research can be published is based upon whether or not it has strong scientific merit, as well as the technicality used to write up the research for the journal.
It is upon a final presentation and review that the journal publishes with the greatest care. Taking great care and discretion with this journal has been helpful in building confidence for those who read the journal as well as those who submit to the journal. Oncotarget is also available on Dove Press.
The medical field is filled with many people doing research who wish to share what they have learned. They often send their research to major medical journals, but there is no guarantee their research will be picked up by the journal. Oncotarget has ensured there is an open forum for the medical research that flies under the radar. This article shows how Oncotarget helps every researcher publish their work for the world to see.
#1: It Is An Open Forum
The journal is open to all, and everyone who wishes to read may do so after starting their account. Oncotarget ensures researchers have a place to share what they have learned, and they may submit multiple studies to the journal for publication. Being open to the medical world ensures everyone with a fine study may publish. Publishing is a requirement for many, and they find what they need when Oncotarget takes their study on.
#2: The Panel Reviews All Studies
There is a fine panel that reviews studies for the journal, and they walk through each new study with the researchers on oncotarget.com. They offer their input to aid in future research, and they prevent researchers from feeling as if they are shouting in the dark when they are completing their work.
#3: Where May Readers Find The Archives?
Archives for the Oncotarget journal are found online, and readers may order the journals online if they wish to read them in print. It is quite possible to find an old journal issue, and the issues have the full copy for the study. All the credits for the studies are listed, and medical professionals may contact the researchers when they wish to learn more about their studies.
The finest research in the medical community is completed in places where the science is not likely to be published. These researchers need a new sort of journal to publish with. They may advance their careers with the journal on ResearchGate.net, and they may use the journal to make a name for themselves. Every new medical study that does not make its way to the largest journals will find a home at Oncotarget with its beautiful website, fine studies and distinguished panel.